Aortic stenosis stages

Jump to navigation Jump to search

Aortic Stenosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Aortic Stenosis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Cardiac Stress Test

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography

Cardiac Catheterization

Aortic Valve Area

Aortic Valve Area Calculation

Treatment

General Approach

Medical Therapy

Surgery

Percutaneous Aortic Balloon Valvotomy (PABV) or Aortic Valvuloplasty

Transcatheter Aortic Valve Replacement (TAVR)

TAVR vs SAVR
Critical Pathway
Patient Selection
Imaging
Evaluation
Valve Types
TAVR Procedure
Post TAVR management
AHA/ACC Guideline Recommendations

Follow Up

Prevention

Precautions and Prophylaxis

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Aortic stenosis stages On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Aortic stenosis stages

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Aortic stenosis stages

CDC on Aortic stenosis stages

Aortic stenosis stages in the news

Blogs on Aortic stenosis stages

Directions to Hospitals Treating Aortic stenosis stages

Risk calculators and risk factors for Aortic stenosis stages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2]; Usama Talib, BSc, MD [3]

Overview

Aortic stenosis can be classified into 7 stages based on the valve's anatomy and hemodynamics as well as the patients symptoms.

Stages

Shown below is a table summarizing the stages of aortic stenosis (AS) according to the 2014 AHA/ACC guidelines for the management of patients with valvular heart disease.[1]

Abbreviations: AR: Aortic regurgitation; AS: Aortic stenosis; AVA: Aortic valve area; LV: Left ventricle; LVEF: Left ventricular ejection fraction

STAGE DEFINITION SYMPTOMS VALVE ANATOMY VALVE HEMODYNAMICS HEMODYNAMIC CONSEQUENCES
A At risk of AS • None • Bicuspid valve
• Valve sclerosis
• Vmax < 2 m/s • None
B Progressive AS • None • Mild-to-moderate calcification
• Rheumatic valve changes with commissural fusion
• Mild AS: Vmax = 2.0-2.9 m/s or mean ΔP < 20 mmHg
• Moderate AS: Vmax = 3.0-3.9 m/s or mean ΔP 20-39 mmHg
• Early LV diastolic dysfunction may be present
• Normal LVEF
C1 Asymptomatic severe AS • None
• Exercise testing to confirm symptom status
• Severe calcification or congenital stenosis with severely reduced opening • Vmax ≥ 4 m/s or mean ΔP ≥ 40 mmHg
• Very severe AS is a Vmax ≥ m/s or mean ΔP ≥ 60 mmHg
• LV diastolic dysfunction
• Mild left ventricular hypertrophy
• Normal LVEF
C2 Asymptomatic severe AS with LV dysfunction • None • Severe calcification or congenital stenosis with severely reduced opening • Vmax ≥ 4 m/s or mean ΔP ≥ 40 mmHg
• AVA ≤ 1.0 cm²
LVEF < 50%
D1 Symptomatic severe high-gradient AS • Exertional dyspnea or decreased exercise tolerance
• Exertional angina
• Exertional syncope or presyncope
• Severe calcification or congenital stenosis with severely reduced opening • Vmax ≥ 4 m/s or mean ΔP ≥ 40 mmHg
• AVA ≤ 1.0 cm² but may be larger with mixed AS and AR
• LV diastolic dysfunction
Left ventricular hypertrophy
• May present with pulmonary hypertension
D2 Symptomatic severe low-flow/low gradient AS with reduced LVEF Heart failure
Angina
Syncope or presyncope
• Severe calcification or congenital stenosis with severely reduced leaflet motion • AVA ≤ 1.0 cm² with resting aortic Vmax < 4 m/s or mean ΔP ≥ 40 mmHg
• Dobutamine stress echo shows AVA ≤ 1.0 cm² with Vmax ≥ 4 m/s at any flow rate
• LV diastolic dysfunction
Left ventricular hypertrophy
LVEF <50%
D3 Symptomatic severe low gradient with normal LVEF Heart failure
Angina
Syncope or presyncope
• Severe calcification with severely reduced leaflet motion • AVA ≤ 1.0 cm² with Vmax < 4 m/s or mean ΔP ≤ 40 mmHg
• AVA ≤ 0.6 cm²
• Stroke volume index < 35 mL/m²
• Increased LV relative wall thickness
• Small LV chamber with low stroke volume
• Restrictive diastolic filling
LVEF ≥ 50%

References

  1. "2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary". Retrieved 4 March 2014.

Template:WH Template:WS CME Category::Cardiology